| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.19 |
4e-05 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |